IHC antibody for Pancreatic Cancer

Immunohistochemical techniques is a methodology which based on antigen-antibody immunological response to its theoretical foundation. It plays an important role in basic and clinical medical research in the field of biology, especially in the diagnosis of diseases of the tumors, differential diagnosis and pathogenesis research provides a powerful tool. With the development of new technologies, hundreds of kinds of antibodies used in various areas of clinical research, the majority of these antibodies play an important supporting role in the diagnosis of difficult cases. It has important implications for the patient's prognosis and guide treatment. In immunohistochemistry, commonly used tumor markers in diagnosis of pancreatic cancer are: PGP, TUBB3, TS, RRM1, TOP2A, ERCC1, EGFR, TLE3 and TOPO1.

Slices of pancreatic cancer as follows:

CGA: 100747-T08

Immunochemical staining of human Chromogranin A in human pancreatic cancerwith rabbit polyclonal antibody (0.5 µg/mL, formalin-fixed paraffin embedded sections).
PTPMT1: 12902-T40

Immunochemical staining of human PTPMT1 in human pancreatic cancerwith rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections).
REG3A: 11235-R019

Immunochemical staining of human REG3A in human pancreatic carcinoma with rabbit monoclonal antibody (5 µg/mL, formalin-fixed paraffin embedded sections).